Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saakshi Medtech and PanelsNSE:SAAKSHI -1.43%50 EBITDA Margin % is 20.61% as of Mar. 2026, which is 22% above its 10-year median of 16.88. GuruFocus rates NSE:SAAKSHI with a GF Score™ of 50/100 and a GF Value™ of ₹220.57 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 3,047 Industrial Products companies, Saakshi Medtech and Panels ranks better than 84.21% on this metric.
Saakshi Medtech and Panels (NSE:SAAKSHI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Saakshi Medtech and Panels EBITDA Margin % Related Terms
Saakshi Medtech and Panels EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SAAKSHI vs VRT, BE: EBITDA Margin % Comparison
For the Electrical Equipment & Parts subindustry, Saakshi Medtech and Panels's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saakshi Medtech and Panels EBITDA Margin % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Saakshi Medtech and Panels's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Saakshi Medtech and Panels's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saakshi Medtech and Panels (NSE:SAAKSHI) has a EBITDA Margin % of 20.61% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Saakshi Medtech and Panels and its competitors. This is 22% above median its historical median of 16.88. Over the past decade, Saakshi Medtech and Panels' EBITDA Margin % has ranged from 10.40 to 20.61. According to the industry distribution chart, Saakshi Medtech and Panels ranks #481 out of 3047 companies in the Industrial Products industry, placing it in the top 15.8%.
Is Saakshi Medtech and Panels' EBITDA Margin % too high?
Saakshi Medtech and Panels' current EBITDA Margin % of 20.61% is 22% above median its 10-year median of 16.88. Over the past 10 years, this metric has ranged from a low of 10.40 to a high of 20.61. The Industrial Products industry median EBITDA Margin % is 9.39. Saakshi Medtech and Panels' value of 20.61% is 119.5% above this industry median. Based on the distribution chart, Saakshi Medtech and Panels ranks #481 out of 3047 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Saakshi Medtech and Panels has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Saakshi Medtech and Panels' EBITDA Margin % compare to VRT and BE?
According to the Industrial Products industry distribution chart, Saakshi Medtech and Panels ranks #481 out of 3047 companies for EBITDA Margin %. This places Saakshi Medtech and Panels in the top 16% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.39. Saakshi Medtech and Panels' value of 20.61% is 119.5% above this benchmark. Historically, Saakshi Medtech and Panels' own EBITDA Margin % has ranged from 10.40 to 20.61 over the past decade. While the company's 10-year median is 16.88 vs. the industry median of 9.39, Saakshi Medtech and Panels has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Industrial Products company?
The median EBITDA Margin % among Industrial Products companies is 9.39, based on 3,047 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saakshi Medtech and Panels's current EBITDA Margin % of 20.61% is 119.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Saakshi Medtech and Panels and its competitors. For the Industrial Products industry, the median EBITDA Margin % is 9.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saakshi Medtech and Panels's current EBITDA Margin % is 20.61%, which is 22% above median its own 10-year median of 16.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saakshi Medtech and Panels stock overvalued right now?
Based on GuruFocus' analysis, Saakshi Medtech and Panels (NSE:SAAKSHI) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹220.57, compared to a current price of ₹345.40 — trading 56.6% above its estimated fair value. The current EBITDA Margin % is 20.61%, which is 22% above median its 10-year median of 16.88 and 119.5% above the Industrial Products industry median of 9.39. Saakshi Medtech and Panels' overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Saakshi Medtech and Panels (NSE:SAAKSHI), the current EBITDA Margin % is 20.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saakshi Medtech and Panels (NSE:SAAKSHI) Overvalued in 2026?
Based on GuruFocus' analysis, Saakshi Medtech and Panels stock appears to be overvalued.
The current stock price of ₹345.40 is trading 56.6% above its estimated GF Value™ of ₹220.57.
GuruFocus considers Saakshi Medtech and Panels to be Significantly Overvalued.
Key valuation signals for NSE:SAAKSHI:
EBITDA Margin %: 20.61% (22% above median its 10-year median of 16.88)
GF Value™: ₹220.57 vs. price of ₹345.40 (56.6% above fair value)
Industry Position: 119.5% above the Industrial Products median (#481 of 3047)
No single metric tells the full story. See the NSE:SAAKSHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saakshi Medtech and Panels Ltd is a diversified company engaged in manufacturing Electrical Control Panels and Cabinets used in elevators, air compressors, renewable energy industry, oil & gas exploration industry, electrical vehicle charging stations, medical X-Ray Systems used in healthcare industry, fabrication works for locomotives, and wire harness division for their captive consumption in electrical control panels and for supply to air compressor industry. Their comprehensive solutions include design, process engineering, and manufacturing including fabrication, assembly, and testing facilities. It designs, programs, and assembles Electrical Control Panels and Cabinets comprising microcontrollers, programmable logic controllers, and SCADA systems.
50GF Score
Get the complete analysis for NSE:SAAKSHI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAAKSHI has been successfully added to your 
